SCHEMBL22837009

SCHEMBL22837009

CC(C)(C)CCOc1cc(C(=O)C(C)(C)C)ccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 3/20 0.39
LTK P29376 1/20 0.39
CDK8 P49336 1/20 0.39
MAP2K1 Q02750 1/20 0.39
ROCK1 Q13464 1/20 0.39
NTRK3 Q16288 1/20 0.39
NTRK2 Q16620 1/20 0.39
CYP2C19 P33261 2/20 0.39
CYP1A2 P05177 1/20 0.39
FABP4 P15090 1/20 0.39
NFKB1 P19838 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
CYP2D6 P10635 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25552341 0.89 CYP2C19 (0.47) LTKCDK8MAP2K1ROCK1NTRK3
SCHEMBL22968687 0.83 HDAC8 (0.40) HDAC8LTKCDK8MAP2K1ROCK1
SCHEMBL22837015 0.83 TTR (0.42) LTKCDK8MAP2K1ROCK1NTRK3
SCHEMBL22837049 0.82 CYP2C19 (0.49) CYP2C19CYP1A2ALDH1A1MEN1POLB
SCHEMBL27831377 0.81 NFKB1 (0.35) HDAC8LTKCDK8MAP2K1ROCK1
SCHEMBL22837047 0.80 THRA (0.43) LTKCDK8MAP2K1ROCK1NTRK3
SCHEMBL13543254 0.79 CYP1A2 (0.46) CYP2C19CYP1A2MEN1MAPTCYP2C9
SCHEMBL22837025 0.76 CNR2 (0.45)
SCHEMBL22837004 0.75 L3MBTL1 (0.49) ALDH1A1MAPTMAPK1L3MBTL1
SCHEMBL22837003 0.75 KMT2A (0.53) MAPTMAPK1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667667-B2 Steroid derivative FXR agonist CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-06-06 US disclosed
US-10875888-B2 Steroid derivative FXR agonist CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2020-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667667-B2 Steroid derivative FXR agonist NR1H4, SLC10A1, FXR1 HDAC8 1344/4885LTK 1091/4885CDK8 3153/4885
US-10875888-B2 Steroid derivative FXR agonist NR1H4, SLC10A1, FXR1 HDAC8 1344/4885LTK 1091/4885CDK8 3153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.